NCT04111302

Brief Summary

Auricular pressure is effective for postoperative analgesia after hemorrhoidectomy, but the evidence is not sufficient.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2020

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 17, 2019

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 1, 2019

Completed
7 months until next milestone

Study Start

First participant enrolled

May 1, 2020

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2023

Completed
Last Updated

February 17, 2020

Status Verified

February 1, 2020

Enrollment Period

2.7 years

First QC Date

September 17, 2019

Last Update Submit

February 13, 2020

Conditions

Keywords

hemorrhoidectiomypostoperative painauricular pressure

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale(VAS)

    It is a unidimensional measure providing a simple solution for measuring subjective experience. The VAS scale is a 10-cm line with 0 cm indicating no symptoms and 10 cm indicates the greatest extent of symptoms.

    Day 1 to 7 and month 3 and 6 after natural allocation

Secondary Outcomes (1)

  • Hospital Anxiety and Depression scale(HAD)

    Three hours, day 3, and day 7 after natural allocation

Other Outcomes (3)

  • The utilization rate of analgesic drugs(Diclofenac Sodium Dual Release Enteric-coated Capsules)

    Day 7 after natural allocation

  • Amount of analgesic drugs (Diclofenac Sodium Dual Release Enteric-coated Capsules)

    Day 7 after natural allocation

  • Tissue edema

    Day 3,day 4,day 5,day 6 and day 7 after natural allocation

Study Arms (4)

IV-PCA

EXPERIMENTAL

use IV-PCA for postoperative pain

Other: IV-PCA

IV-dezocine

EXPERIMENTAL

use IV-dezocine for postoperative pain

Other: IV-dezocine

IV-PCA+AA

EXPERIMENTAL

use IV-PCA and AA for postoperative pain

Other: IV-PCA+AA

IV-dezocine+AA

EXPERIMENTAL

use IV-dezocine and AA for postoperative pain

Other: IV-dezocine+AA

Interventions

IV-PCAOTHER

IV-PCA contains dezocine 10mg, sufentanil 100ug, metoclopramide 20mg and normal saline are prepared into 100ml solution and pumped evenly at the speed of 2ml/h.

IV-PCA

IV-dezocine contains dezocine 5mg and 250ml normal saline are made into solution and injected intravenously twice a day for 3 consecutive days after surgery.

IV-dezocine

IV-PCA contains dezocine 10mg, sufentanil 100ug, metoclopramide 20mg and normal saline are prepared into 100ml solution and pumped evenly at the speed of 2ml/h. And selecting the auricular points TF4, AH6a, HX2, HX5, CO4, AT4 and cowherb seeds will be attached to each auricular point after the auricle skin is disinfected. The participants will be asked to press the cowherb seeds against the auricular points every 2 hours during waking hours; each point is stimulated for one minute. Auricular points are pressed unilaterally, and the cowherb seeds will be replaced with new ones every 2 days, alternating from left to right.

IV-PCA+AA

IV-dezocine contains dezocine 5mg and 250ml normal saline are made into solution and injected intravenously twice a day for 3 consecutive days after surgery.And selecting the auricular points TF4, AH6a, HX2, HX5, CO4, AT4 and cowherb seeds will be attached to each auricular point after the auricle skin is disinfected. The participants will be asked to press the cowherb seeds against the auricular points every 2 hours during waking hours; each point is stimulated for one minute. Auricular points are pressed unilaterally, and the cowherb seeds will be replaced with new ones every 2 days, alternating from left to right.

IV-dezocine+AA

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meet the diagnostic criteria of grade II-IV mixed hemorrhoids and meet the operation conditions;
  • Age 18\~65;
  • External stripping and internal ligation of mixed hemorrhoids, general anesthesia or lumbar shu point anesthesia;
  • VAS score ≥3 points;
  • Sign informed consent.

You may not qualify if:

  • Combined cognitive impairment could not complete the efficacy evaluation;
  • With other gastrointestinal conditions found during operation;
  • With severe cardiovascular, hepatic, or renal diseases;
  • With opioid addiction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Analgesia, Patient-Controlled

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

AnalgesiaAnesthesia and Analgesia

Study Officials

  • Hui Zheng, phD

    Chengdu University of Traditional Chinese Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Wenyan Peng, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 17, 2019

First Posted

October 1, 2019

Study Start

May 1, 2020

Primary Completion

January 1, 2023

Study Completion

May 1, 2023

Last Updated

February 17, 2020

Record last verified: 2020-02